High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers-Reference-Cited by-同舟云学术

High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers

Published:2015-11 Issue:11 Volume:26 Page:2293-2300
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Castro E.,Jugurnauth-Little S.,Karlsson Q.,Al-Shahrour F.,Piñeiro-Yañez E.,Van de Poll F.,Leongamornlert D.,Dadaev T.,Govindasami K.,Guy M.,Eeles R.,Kote-Jarai Z.

Funder

Institute of Cancer Research

Prostate Cancer Clinical Research Unit at Spanish National Cancer Research Centre

Fundación CRIS contra el cancer

Institute of Cancer Research (ICR

Royal Marsden NHS Foundation Trust

NIHR

Biomedical Research Centre at The Institute of Cancer Research

the United Kingdom Genetic Prostate Cancer Study

Cancer Research UK

Ronald and Rita McAulay Foundation and Cancer Research UK

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/11/2293/16699077/mdv356.pdf

Reference36 articles.

1. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients;Kote-Jarai;Br J Cancer,2011

2. Prostate cancer progression and survival in BRCA2 mutation carriers;Tryggvadottir;J Natl Cancer Inst,2007

3. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer;Castro;J Clin Oncol,2013

4. Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis;Edwards;Br J Cancer,2010

5. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer;Gallagher;Clin Cancer Res,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From microscopes to molecules: The evolution of prostate cancer diagnostics;Cytojournal;2024-08-29

2. FABP6 serves as a new therapeutic target in esophageal tumor;Aging;2024-01-25

3. Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility;British Journal of Cancer;2023-11-09

4. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers;European Journal of Cancer;2023-05

5. Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer;European Urology;2023-02